Clinical Trial Update: Epanova® Compared to Lovaza® In a Pharmacokinetic, Single-dose, Evaluation [Phase 2]

View source ↗

Summary

Phase 2 pharmacokinetic, single-dose study comparing Epanova to Lovaza in adults with severe hypertriglyceridemia. The trial assessed pharmacokinetic outcomes o…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertriglyceridemia

Drugs mentioned

• Epanova (icosapent ethyl)
• LOVAZA (OMEGA-3-ACID ETHYL ESTERS)

Snippet

Sponsor: AstraZeneca | Conditions: Severe Hypertriglyceridemia | Phase 2 | Status: COMPLETED | Results posted: 2014-01-06